Today: 7 February 2026
Subscribe
Browse Category

Stock Analysis News 8 November 2025 - 14 November 2025

Akanda Corp. (AKAN) Today: Full Cultivation License Push, Telecom Growth and Stock Reaction – November 14, 2025

Akanda Corp. (AKAN) Today: Full Cultivation License Push, Telecom Growth and Stock Reaction – November 14, 2025

Akanda Corp. (NASDAQ: AKAN) is back in the news today after outlining the next steps toward a full Health Canada cultivation license at its British Columbia cannabis site, while commentators highlight the company’s unusual mix of Mexican telecom infrastructure and Canadian cannabis “optionality.” Newsfile+1 A fresh Newsfile press release this morning details how Akanda will design and implement Health Canada–compliant security at its Gabriola Island facility, a prerequisite for producing THC- and CBD-rich cannabis under a full cultivation license. Newsfile+1 At the same time, a new MarketScreener feature frames Akanda as a “dual‑track” small cap: cash flow from towers and
14 November 2025
·
Applied Materials (AMAT) Stock Slides as China Export Curbs Cloud Outlook Despite Q4 2025 Earnings Beat

Applied Materials (AMAT) Stock Slides as China Export Curbs Cloud Outlook Despite Q4 2025 Earnings Beat

Applied Materials (NASDAQ: AMAT) beat fiscal Q4 2025 earnings expectations, but AMAT stock fell around 5–7% on November 14 as U.S. export controls and weaker China spending weighed on the 2026 outlook. Key takeaways Q4 2025: Earnings beat and record year, but slower growth Applied Materials, the world’s largest semiconductor equipment maker, reported fiscal Q4 2025 results for the quarter ended October 26, 2025, on Thursday evening, followed by a sharp market reaction on Friday, November 14. GlobeNewswire+1 Revenue and profit According to the company’s earnings release: For the full fiscal year 2025: In other words, top‑line growth slowed, but
14 November 2025
··
Strategy (MSTR) prices €620M euro preferred to buy more Bitcoin as stock nears 7‑month low; options traders eye bear call spreads

MSTR Stock Today (Nov. 14, 2025): Strategy’s Market Cap Brushes Against Its Bitcoin Hoard as Shares Hit 13‑Month Lows

Strategy Inc. (NASDAQ: MSTR) — the company formerly known as MicroStrategy and still traded under the ticker MSTR — is back in the spotlight today as its stock continues to slide alongside a sharp pullback in Bitcoin. At last check on Friday, MSTR was trading around $208–$210 per share, hovering just above a new 52‑week low after a steep drop on Thursday. The stock is now down roughly 30% year‑to‑date and more than 50% from its 2025 peak, even though Bitcoin itself remains slightly positive for the year. Coin Edition At the same time, the company’s enormous Bitcoin treasury —
14 November 2025
··
Cisco Stock Surges Near 52-Week High on AI Momentum – What’s Next for CSCO?

Cisco Stock (CSCO) Jumps on AI‑Fueled Outlook After Q1 Beat — Price, Guidance, and Analyst Targets for November 13, 2025

Updated Nov. 13, 2025 — 23:31 UTC Cisco stock today: Shares of Cisco Systems (NASDAQ: CSCO) traded around $77.38, up ~4.7% intraday, with a session range of $76.69–$79.58 as of 23:31 UTC. Earlier, the stock also surged in European trading after the company raised its full‑year outlook. Reuters What’s moving Cisco stock today Cisco’s rally follows strong fiscal Q1 (October‑quarter) results and a higher full‑year outlook tied to accelerating demand for AI networking hardware and campus upgrades. Management highlighted $1.3 billion in AI infrastructure orders from hyperscalers in Q1 and projected FY26 revenue of $60.2–$61.0 billion with non‑GAAP EPS of
14 November 2025
··
Pfizer Stock Plunge and Promise: Vaccine Slump, Weight-Loss War, and a $10B Gamble – Is PFE Poised for a Comeback?

Pfizer Stock Today, November 13, 2025: BioNTech Stake Sale, Metsera Deal and a 6%+ Dividend Put PFE Back in Focus

Pfizer stock (NYSE: PFE) is trading higher today as investors digest a fresh batch of headlines: a planned sale of the company’s remaining stake in Covid-19 vaccine partner BioNTech, ongoing reaction to its $10 billion Metsera obesity-drug deal, and renewed debate around whether PFE’s rich dividend compensates for its strategic risks. As of the latest quotes on Thursday, November 13, Pfizer shares are changing hands around $25.9, up roughly 1.4% on the day after trading between about $25.3 and $25.9 in today’s session. That puts the company’s market capitalization near $147 billion, with the stock still trading on a single-digit earnings multiple and yielding around 6.6–7% on a
13 November 2025
···
AB InBev (BUD) Today — Nov. 11, 2025: Morgan Stanley Trims Price Target as Buyback Progresses; DZ Bank Reiterates ‘Buy’ and Valuation Debates Heat Up

AB InBev (BUD) Today — Nov. 11, 2025: Morgan Stanley Trims Price Target as Buyback Progresses; DZ Bank Reiterates ‘Buy’ and Valuation Debates Heat Up

Updated: November 11, 2025Tickers: NYSE: BUD · Euronext Brussels: ABI Key points What changed today Morgan Stanley trims but stays bullish. In a Tuesday note, Morgan Stanley reduced its AB InBev price target to $79while maintaining Overweight. The team cut organic volume expectations for FY25 and grew more cautious for early 2026, but nudged FY25 organic EBITDA growth a touch higher after Q3. Higher finance costs (including BRL hedging) and lower volumes drive the model changes; even so, the bank said its EPS forecasts remain above Visible Alpha consensus. (Investing.com) Share buyback momentum. After unveiling a $6bn program alongside Q3 results in late October, AB InBev
11 November 2025
···
Hesai Group (HSAI) Turns Profitable in Q3, Wins Exclusive Li Auto Lidar Deal, and Guides Stronger Q4 — Nov. 11, 2025

Hesai Group (HSAI) Turns Profitable in Q3, Wins Exclusive Li Auto Lidar Deal, and Guides Stronger Q4 — Nov. 11, 2025

Hesai Group (NASDAQ: HSAI; HKEX: 2525) delivered two headlines today: a return to profitability on record quarterly results and a fresh commercial win as the exclusive lidar supplier for Li Auto’s next‑generation assisted‑driving platform. Management also guided to double‑digit growth for Q4, underscoring momentum in both ADAS and robotics lidar shipments. Quiver Quantitative+2PR Newswire+2 Key takeaways By the numbers: Hesai’s record quarter Hesai reported RMB 795.4 million in Q3 net revenue, up 47.5% year on year, and shipped 441,398 lidar sensors, including 380,759 for ADAS and 60,639 for robotics. Gross margin came in at 42.1%, while net income reached RMB
11 November 2025
··
Beachbody (BODI) Jumps After First GAAP Profit; Canaccord Lifts Price Target to $9 — What Investors Need to Know Today (Nov. 11, 2025)

Beachbody (BODI) Jumps After First GAAP Profit; Canaccord Lifts Price Target to $9 — What Investors Need to Know Today (Nov. 11, 2025)

The Beachbody Company, Inc. (NASDAQ: BODI) is back in the headlines one day after reporting its first GAAP net profit since going public in 2021. Shares were among the morning’s biggest pre‑market movers and an analyst at Canaccord Genuity boosted the stock’s price target to $9, citing improving profitability trends. StreetInsider.com+3Business Wire+3 Key takeaways By the numbers: Q3 2025 (quarter ended Sept. 30) Management framed Q3 as a proof point that the company’s multi‑year transformation is working, with a leaner cost structure and higher margin mix leading to profitability ahead of plan. Business Wire Q4 2025 outlook BODI guided revenue
11 November 2025
···
Canada Goose (GOOS): Fresh 13F Moves, Buyback Launch, and New Analyst Targets — What Investors Need to Know Today (Nov. 11, 2025)

Canada Goose (GOOS): Fresh 13F Moves, Buyback Launch, and New Analyst Targets — What Investors Need to Know Today (Nov. 11, 2025)

What changed today (Nov. 11, 2025) The most recent developments as of Tuesday, Nov. 11 revolve around post‑earnings positioning and new sell‑side targets. Barclays cut its 12‑month price target to $11 while maintaining Equal‑Weight, citing a more cautious view after last week’s results. UBS raised its target to $12 but stayed Neutral, reflecting improving momentum but limited near‑term conviction. GuruFocus+1 Meanwhile, the company’s renewed normal course issuer bid (NCIB) formally began on Nov. 10, enabling buybacks of up to 4.58M shares over the next 12 months—about 10% of the public float—potentially providing a modest support to per‑share metrics during volatility.
11 November 2025
····
Viking Therapeutics (VKTX) Today — Nov 9, 2025: New Institutional Buying, Fresh Technical Levels, and Key Catalysts Ahead

Viking Therapeutics (VKTX) Today — Nov 9, 2025: New Institutional Buying, Fresh Technical Levels, and Key Catalysts Ahead

Market snapshot Last close (Fri, Nov 7): $36.77.Intraday range: $34.69 – $37.50; volume: ~4.65M. Why VKTX is back on watch this week 1) Fresh institutional interest and ownership trends Ethos Financial Group’s new position adds to a year when institutions already control roughly three‑quarters of the float. MarketBeat’s automated brief also captures the latest insider activity (including October sales by the CEO and a director), and a blended “Moderate Buy” Street view. While 13F adds don’t guarantee direction, they often increase visibility ahead of catalysts. MarketBeat 2) Technical picture: mixed near‑term, firmer mid‑term Today’s quant readout pegs $35–$38 as the
9 November 2025
··
Primerica (PRI) Today: Truist Reaffirms $340 Price Target After Record Q3 ISP Sales; Institutions Shuffle Stakes — Nov. 9, 2025

Primerica (PRI) Today: Truist Reaffirms $340 Price Target After Record Q3 ISP Sales; Institutions Shuffle Stakes — Nov. 9, 2025

What’s new today (Nov. 9, 2025) Institutional positioning headlines are in focus. MarketBeat reports that Bank of New York Mellon Corp increased its PRI stake to about 318,653 shares (≈0.96% of the company), while separate filings show Vestmark Advisory Solutions sold 20,797 PRI shares. These are incremental moves but reinforce the theme of active rotation following last week’s results. MarketBeat+1 Meanwhile, Truist’s post-earnings research remains supportive: the firm reaffirmed a $340 target and raised its EPS forecasts to $21.42 (2025) and $23.57 (2026), pointing to accelerating annuity momentum and broad ISP tailwinds. Investing.com UK Analyst angle: Why the $340 target
9 November 2025
····
Qualys (QLYS) News Roundup for Nov. 7–8, 2025: Analyst Upgrade, EPS Estimate Lift, and Stock Holds Near $150 After Q3 Beat

Qualys (QLYS) News Roundup for Nov. 7–8, 2025: Analyst Upgrade, EPS Estimate Lift, and Stock Holds Near $150 After Q3 Beat

Dateline: November 8, 2025 — Cybersecurity vendor Qualys, Inc. (NASDAQ: QLYS) stayed in the headlines heading into the weekend, with fresh analyst reactions following Tuesday’s earnings beat, a state pension fund disclosing a larger stake, and continued chatter around its agentic‑AI roadmap. Below is a concise, Google News–ready digest of everything new about Qualys published November 7–8, 2025. Key Points at a Glance Today — Saturday, Nov. 8, 2025 Analyst upgrade to “Buy.” MarketBeat reports that Wall Street Zen upgraded Qualys shares to Buy today, pointing to the company’s updated FY25 outlook following this week’s results. While this is one
8 November 2025
···
1 … 61 62 63 64 65 … 69

Stock Market Today

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 07.02.2026

7 February 2026
LIVEMarkets rolling coverageStarted: February 7, 2026, 12:00 AM ESTUpdated: February 7, 2026, 12:11 AM EST CleanSpark (CLSK) Shares Show Volatility Amid Bitcoin Mining Growth Prospects February 7, 2026, 12:02 AM EST. CleanSpark (CLSK), a bitcoin mining firm, saw a sharp 21.96% rise in one day after a 35.26% decline over 90 days. The company posted $785 million in annual revenue but a net loss of $267 million. Despite recent share price volatility, analysts estimate a fair value of $23.16 per share, more than double the current $10.08 price, reflecting expectations of expansion in mining capacity and improved margins. The valuation
Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Go toTop